The capital market regulator, the Securities and Exchange Board of India (SEBI) has recently approved Dr. Agarwal’s, Casagrand Premier, and Regreen Excel EPC to raise funds via IPO. In this blog, we will explore the details of these upcoming IPOs.
Dr Agarwal Health Care, backed by Temasek Holdings and TPG, received SEBI’s approval on January 8, 2025, to move forward with its ₹300 crore IPO. The company submitted its draft documents to SEBI on September 27, 2024.
The IPO will consist of a fresh issuance of equity shares worth up to ₹300 crore, along with an offer for sale (OFS) of up to 69.57 million shares by promoters and other shareholders. The OFS will include significant stakes from Dr Amar Agarwal, Dr Athiya Agarwal, Dr Adil Agarwal, and institutional investors like Hyperion Investments Pte. Ltd and Claymore Investments (Mauritius) Pte. Ltd.
The book-running lead managers for this IPO are Kotak Mahindra Capital, Morgan Stanley India, Jefferies India, and Motilal Oswal Investment Advisors, while KFin Technologies will serve as the registrar.
Regreen Excel’s IPO comprises a fresh issue of equity shares worth up to ₹350 crore and an OFS of up to 11,450,380 shares by the promoter’s selling shareholders.
The company plans to use the net proceeds from the fresh issue to fund capital expenditure, repay or pre-pay certain borrowings, cover margin money for bank guarantees, and for general corporate purposes.
IIFL Securities Limited and ICICI Securities Limited are the Book Running Lead Managers for this issue.
Casagrand Premier has also received SEBI’s final observation to raise ₹1,100 crore through its IPO. Casagrand Premier IPO, with a face value of ₹2 per share, includes a fresh issuance of up to ₹1,000 crore and an OFS of up to ₹100 crore from the promoters. The company, in consultation with the book-running lead managers, may consider a further issue of equity shares worth up to ₹200 crore, though the pre-IPO placement will not exceed 20% of the fresh issue size, potentially reducing the fresh issue amount.
JM Financial Limited and Motilal Oswal Investment Advisors Limited are the book-running lead managers, and KFin Technologies Limited will be the registrar for the offer.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jan 9, 2025, 12:41 PM IST
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
